Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
GENE EDITOR FOR DISEASE TREATMENT AND NUCLEIC ACID PHARMACEUTICAL COMPOSITION FOR ANTI-FIBROSIS INHIBITOR
Document Type and Number:
WIPO Patent Application WO/2024/088384
Kind Code:
A1
Abstract:
Provided in the present invention are a gene editor for disease treatment and a nucleic acid pharmaceutical composition for an anti-fibrosis inhibitor. Specifically, the pharmaceutical composition contains: (a) a first active ingredient, which is a gene editor for performing base editing on a target gene; and (b) a second active ingredient, which is an anti-fibrosis inhibitor. In the present invention, a nucleic acid sequence encoding the gene editor and the anti-fibrosis inhibitor is treated on a genetic disease by means of using a viral or non-viral vector system, so that a gene can be repaired while fibrosis signals in the micro-environment can be inhibited, thereby achieving a synergistic therapeutic effect.

Inventors:
HE CHUNYAN (CN)
LI FENGPENG (CN)
XIAO GUANGYUAN (CN)
Application Number:
PCT/CN2023/127083
Publication Date:
May 02, 2024
Filing Date:
October 27, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SUZHOU GENASSIST THERAPEUTICS CO LTD (CN)
International Classes:
A61K48/00; A61K39/395; A61P11/00; C07K14/47; C12N15/63
Attorney, Agent or Firm:
XU & PARTNERS, LLC. (CN)
Download PDF: